Thursday, September 19, 2024
HomeTagsConfo Therapeutics

Confo Therapeutics

Confo Therapeutics Announces EUR 60M Series B Financing to Advance Pipeline of Novel GPCR-Modulating Therapies into Clinical Development

Confo Therapeutics, a clinical-stage company and leader in the discovery of medicines targeting G-protein coupled receptors (GPCRs), announced the closing of a EUR 60M...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics